en

Sign up
Investments involve risks and are not suitable for all investors.
Home・Stock List・Laboratorios Farmaceuticos Rovi SA
Search

Laboratorios Farmaceuticos Rovi SA

Closed

80.2 1.84

Buy

Price update 6 Sept 2024, 15:29 UTC

BuySell

Overview

Share price change

24h

Current

Min

80.15

Max

80.45

Key metrics

By Trading Economics

Income

15M

Sales

-297M

151M

P/E

Sector Avg

24.61

EPS

0.292

Profit margin

9.896

EBITDA

26M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+22.52 upside

Market Stats

By TradingEconomics

Market Cap

-23M

4.1B

Previous open

78.36

Previous close

80.2

News Sentiment

By Acuity

50%

50%

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

78.2 / N/A Support & Resistance

Laboratorios Farmaceuticos Rovi SA Chart

Related News

7 Sept 2024, 09:30 UTC

Top News

Jobs Slowdown Frustrates Investors Who Wanted Certainty on the Fed -- WSJ

DJ

Read

7 Sept 2024, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

6 Sept 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

DJ

Read

6 Sept 2024, 21:18 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

DJ

Read

6 Sept 2024, 21:05 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

DJ

Read

6 Sept 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

6 Sept 2024, 20:39 UTC

Earnings

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

DJ

Read

6 Sept 2024, 20:35 UTC

Top News

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

DJ

Read

6 Sept 2024, 20:34 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

DJ

Read

6 Sept 2024, 20:11 UTC

Top News

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

DJ

Read

6 Sept 2024, 19:51 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

DJ

Read

6 Sept 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

DJ

Read

6 Sept 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

DJ

Read

6 Sept 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

DJ

Read

6 Sept 2024, 18:27 UTC

Top News

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

DJ

Read

6 Sept 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

DJ

Read

6 Sept 2024, 18:15 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

DJ

Read

6 Sept 2024, 18:12 UTC

Top News

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

DJ

Read

6 Sept 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

DJ

Read

6 Sept 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

DJ

Read

6 Sept 2024, 17:30 UTC

Top News

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

DJ

Read

6 Sept 2024, 17:27 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

DJ

Read

6 Sept 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

6 Sept 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

DJ

Read

6 Sept 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

DJ

Read

6 Sept 2024, 16:35 UTC

Earnings
Hot Stocks

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

DJ

Read

6 Sept 2024, 16:33 UTC

Acquisitions, Mergers, Takeovers

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

DJ

Read

6 Sept 2024, 16:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

6 Sept 2024, 16:20 UTC

Earnings

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

DJ

Read

6 Sept 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

Laboratorios Farmaceuticos Rovi SA Forecast

Price Target

By TipRanks

22.52% upside

12 Months Forecast

Average 99 EUR  22.52%

High 104 EUR

Low 94 EUR

Based on 2 Wall Street analysts offering 12 month price targets forLaboratorios Farmaceuticos Rovi SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Laboratorios Farmaceuticos Rovi SA - Dist in the past 3 months.

Technical Score

By Trading Central

78.2 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bearish Evidence

Bearish events outweigh bullish events.

Long Term

Weak Bullish Evidence

All events are bullish.

Sentiment

By Acuity

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.